AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients With High Cardiovascular Risk and Elevated Low-Density Lipoprotein Cholesterol (ORION-3)

10,698 views
November 30, 2022
7 Comments
Login to view comments. Click here to Login